Search NLS News

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. Read more: Highlights from BIO International Convention 2023 Read more about BIO International Convention here!

Ono Pharmaceutical Co., Ltd. is one of Japan’s largest pharmaceutical companies. In 2016, in addition to the creation of a new Chemical Process R&D center, Ono Pharmaceuticals implemented Vaisala’s viewLinc Continuous Monitoring System to monitor controlled environments and cGMP-regulated applications. Ono Pharmaceutical Co., Ltd. is one of Japan’s largest pharmaceutical companies. Their history goes back […]

Join scientists working with interaction analysis at DiPIA 2024—secure your spot today! DiPIA, or Developments in Protein Interaction Analysis, is a global scientific conference hosted by Cytiva, taking place in Kista (Kistamässan Exhibition & Congress Centre), Sweden on September 9-12. We unite peers from across the industry to share best practices, research, and new applications. This […]

The company has decided to discontinue the preclinical development of the lipodystrophy project CGT2. After receiving data that was difficult to interpret during the course of the project, CombiGene conducted additional studies in 2023 to provide a basis for a correct assessment of the project. Now that these studies have been completed, the company can […]

The company has announced the appointment of Kristen Harting, MD, as Chief Medical Officer (CMO), effective 15 February 2024. She will lead all clinical development and medical affairs and report to the CEO. Harting brings more than 30 years’ experience to the SynAct team and the company’s push to advance the lead drug candidate resomelagon […]

We are excited to invite you to our upcoming webinar, “Targeted Protein Degradation – New Modalities and Design Technologies”, scheduled for June 20, 2024. This online event will feature experts Dr. Bernhard Fasching and Dr. Benedict Cross, who will look into the latest advancements in drug discovery techniques. This session will explore new modalities in […]

If approved, AstraZeneca and Daiichi Sankyo’s Enhertu will potentially be the first HER2-directed treatment and antibody drug conjugate to receive a tumor-agnostic indication. AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-positive […]

Research Director Satu Palva has been appointed the new Director of the Neuroscience Center within Helsinki Institute of Life Science. Palva’s 5-year term started on February 1, 2024. According to Jari Koistinaho, Director of the Helsinki Institute of Life Sciences HiLIFE, Palva’s recruitment is an important step in further strengthening the life sciences portfolio of the […]

Immunovia has announced the appointment of Norma Alonzo Palma, PhD, as Vice President of Clinical and Medical Affairs. As announced in July 2023, Immunovia significantly restructured to focus its resources on the company’s blood test for early detection of pancreatic cancer. Norma’s appointment will enable Immunovia to move into the next phase, where her primary […]

For the past decade, Nordic Life Science Days (NLSDays) has been building business partnerships, highlighting innovations and showcasing all that the Nordic countries have to offer in the life science field. Read more: Highlights from NLSDays 2023 Read more about NLSDays 2024 here!